To explore the molecular mechanism of MA in the treatment of T2DM, we selected PIK3R1, PCK1, IL1B, and MIR 29A to investigate their expression level changes by qRT-PCR. This evidence concerns the gene PIK3R1 and type 2 diabetes mellitus.